Taysha Gene Therapies (NASDAQ: TSHA - Get Free Report) and MediWound (NASDAQ: MDWD - Get Free Report

MediWound Awarded Additional $3.3 Million from U.S. Department of War to Advance Room-Temperature-St

Independent DSMB Recommends MediWound's EscharEx ® Phase III VALUE Study Continue Without Modificati

MediWound to Present at the H.C. Wainwright 28 th Annual Global Investment Conference YAVNE, Israel,

Oppenheimer analyst Jeff Jones maintains MediWound (NASDAQ:MDWD) with a Outperform and lowers the

MediWound Ltd. (MDWD) Q2 2026 Earnings Call Transcript

MediWound NASDAQ: MDWD reported second-quarter 2026 revenue of $3.1 million, down from $5.7 million

MediWound (NASDAQ:MDWD) held its second-quarter earnings conference call on Thursday. Below is the c

MediWound (MDWD) came out with a quarterly loss of $0.77 per share versus the Zacks Consensus Estima

MediWound (NASDAQ:MDWD) reported quarterly losses of $(0.77) per share which missed the analyst cons

MediWound (NASDAQ:MDWD) affirms FY2026 sales outlook from $24.000 million-$26.000 million to $24.000

EscharEx ® Phase III VALUE Trial Advancing; Interim Assessment and Enrollment Completion Expected by

MediWound to Report Second Quarter 2026 Financial Results Conference Call and Webcast Scheduled for

MediWound Ltd. (MDWD) Q1 2026 Earnings Call Transcript

MediWound NASDAQ: MDWD reported a wider first-quarter loss and lower revenue compared with the prior

MediWound (MDWD) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estima

EscharEx ® Phase III VALUE trial advancing; interim assessment and enrollment completion expected by

MediWound to Report First Quarter 2026 Financial Results Conference Call and Webcast Scheduled for W

Surrozen (NASDAQ: SRZN - Get Free Report) and MediWound (NASDAQ: MDWD - Get Free Report) are both sm

Newly Published U.S. Expert Consensus Aligns with MediWound's Strategy for Chronic Wound Debridement

MediWound to Present New EscharEx ® Data at Leading Wound Care Conferences   Data highlights mechani

Dyne Therapeutics (NASDAQ: DYN - Get Free Report) and MediWound (NASDAQ: MDWD - Get Free Report) are

MediWound Reports BARDA Contract Award to Vericel for NexoBrid ® Valued at up to $197 Million YAVNE,

MediWound Ltd. (MDWD) Q4 2025 Earnings Call Transcript

Shares of NIO Inc. (NYSE:NIO) fell sharply during Friday's session after the company disclosed t

Shares of Sharps Technology, Inc. (NASDAQ:STSS) rose sharply in today's pre-market trading after

Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarte

Companies Reporting Before The Bell • Golden Ocean Group (NASDAQ:GOGL) is likely to report quarterl

  Friday's session saw 225 companies set new 52-week lows.

  On Thursday, 283 companies set new 52-week lows.

  On Wednesday, 179 companies reached new 52-week lows.

Companies Reporting Before The Bell • Mainz Biomed (NASDAQ:MYNZ) is projected to report earnings fo

Companies Reporting Before The Bell • KVH Industries (NASDAQ:KVHI) is projected to report quarterly

  Tuesday's session saw 167 companies set new 52-week lows.

Companies Reporting Before The Bell • Alkaline Water Co (NASDAQ:WTER) is likely to report quarterly

  Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to repor

    On Monday, 524 stocks hit new 52-week lows.

Gainers Indonesia Energy Corporation Limited (NASDAQ: INDO) shares climbed 39.3% to close at $20

  Companies Reporting Before The Bell • PG&E (NYSE:PCG) is likely to report quarterly earnings

    During the morning session on Friday, 389 stocks hit new 52-week highs.

    Before 10 a.m. ET Thursday, 503 stocks hit new 52-week highs.

    Before 10 a.m. ET on Wednesday, 285 companies set new 52-week highs.

  Companies Reporting Before The Bell • Advance Auto Parts (NYSE:AAP) is projected to report quart